Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Mattiuz, R. Franklin, T. Gillespie, A. Murphy, J. Bernstein, A. Chiu, T. Hotten, K. Kassahun (1997)
Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys.Drug metabolism and disposition: the biological fate of chemicals, 25 5
H. Keselman, B. Holland, Robert Cribbie (2005)
Multiple Comparison Procedures
P. Perry, B. Lund, T. Sanger, Charles Beasley (2001)
Olanzapine Plasma Concentrations and Clinical Response: Acute Phase Results of the North American Olanzapine TrialJournal of Clinical Psychopharmacology, 21
V. Howard, Matthew Reed (1998)
Unbiased Stereology: Three-Dimensional Measurement in Microscopy
H. Haug (1986)
History of neuromorphometryJournal of Neuroscience Methods, 18
H. Gundersen, E. Jensen, K. Kiêu, J. Nielsen (1999)
The efficiency of systematic sampling in stereology — reconsideredJournal of Microscopy, 193
R. Sweet, J. Pierri, S. Auh, A. Sampson, D. Lewis (2003)
Reduced Pyramidal Cell Somal Volume in Auditory Association Cortex of Subjects with SchizophreniaNeuropsychopharmacology, 28
J. Pierri, Adil Chaudry, T. Woo, D. Lewis (1999)
Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects.The American journal of psychiatry, 156 11
R. Gur, Veda Maany, P. Mozley, C. Swanson, Warren Bilker, R. Gur (1998)
Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia.The American journal of psychiatry, 155 12
R. Apiquián, A. Fresán, K. Herrera, R. Ulloa, C. Lóyzaga, C. Fuente-Sandoval, Doris Gutiérrez, H. Nicolini (2003)
Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine.The international journal of neuropsychopharmacology, 6 4
G. Rajkowska, L. Selemon, P. Goldman-Rakic (1998)
Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease.Archives of general psychiatry, 55 3
P. Perry, T. Sanger, C. Beasley (1997)
Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients.Journal of clinical psychopharmacology, 17 6
P. Gadeberg, H. Gundersen, F. Taagehøj, J. Jakobsen (2002)
MRI volume measurements of hypointense objects A phantom study using stereological methodsJournal of Neuroscience Methods, 114
B. Pakkenberg (1993)
Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectorsBiological Psychiatry, 34
S. Kapur, R. Zipursky, G. Remington (1999)
Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.The American journal of psychiatry, 156 2
Paul Harrison, N. Freemantle, J. Geddes (2003)
Meta-analysis of brain weight in schizophreniaSchizophrenia Research, 64
M. Chakos, J. Lieberman, J. Alvir, R. Bilder, M. Ashtari (1995)
Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapineThe Lancet, 345
W. Scherle (1970)
A simple method for volumetry of organs in quantitative stereology.Mikroskopie, 26 1
L. Marner, B. Pakkenberg (2003)
Total length of nerve fibers in prefrontal and global white matter of chronic schizophrenics.Journal of psychiatric research, 37 6
RC Littell, GA Milliken, WW Stroup, RD Wolfinger (1996)
SAS System for Mixed Models
J. McEvoy, G. Hogarty, S. Steingard (1991)
Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose.Archives of general psychiatry, 48 8
(2003)
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison
J. McEvoy (1986)
Relief from catatonic immobility can be maintained.Journal of clinical psychopharmacology, 6 2
Ole Olesen, Kristian Linnet (1998)
Determination of olanzapine in serum by high-performance liquid chromatography using ultraviolet detection considering the easy oxidability of the compound and the presence of other psychotropic drugs.Journal of chromatography. B, Biomedical sciences and applications, 714 2
J. Thune, H. Uylings, B. Pakkenberg (2001)
No deficit in total number of neurons in the prefrontal cortex in schizophrenics.Journal of psychiatric research, 35 1
S. Weis, H. Haug, H. Budka (1996)
Vascular changes in the cerebral cortex in HIV-1 infection: I. A morphometric investigation by light and electron microscopy.Clinical neuropathology, 15 6
S. Arnold, B. Franz, R. Gur, R. Gur, R. Shapiro, P. Moberg, J. Trojanowski (1995)
Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions.The American journal of psychiatry, 152 5
K. Kassahun, E. Mattiuz, Eldon Nyhart, Boyd Obermeyer, Todd Gillespie, A. Murphy, R. Goodwin, David Tupper, J. Callaghan, Louis Lemberger (1997)
Disposition and biotransformation of the antipsychotic agent olanzapine in humans.Drug metabolism and disposition: the biological fate of chemicals, 25 1
K. Davis, Daniel Stewart, J. Friedman, M. Buchsbaum, Philip Harvey, P. Hof, J. Buxbaum, V. Haroutunian (2003)
White matter changes in schizophrenia: evidence for myelin-related dysfunction.Archives of general psychiatry, 60 5
P. Corson, P. Nopoulos, D. Miller, S. Arndt, Stephan Arndt, N. Andreasen (1999)
Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics.The American journal of psychiatry, 156 8
M. Akil, J. Pierri, R. Whitehead, C. Edgar, C. Mohila, A. Sampson, D. Lewis (1999)
Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.The American journal of psychiatry, 156 10
M. García-Fiñana, L. Cruz-Orive, C. Mackay, B. Pakkenberg, N. Roberts (2003)
Comparison of MR imaging against physical sectioning to estimate the volume of human cerebral compartmentsNeuroImage, 18
Y. Okubo, T. Saijo, K. Oda (2001)
A review of MRI studies of progressive brain changes in schizophrenia.Journal of medical and dental sciences, 48 3
F. Benes, I. Sorensen, E. Bird (1991)
Reduced neuronal size in posterior hippocampus of schizophrenic patients.Schizophrenia bulletin, 17 4
R. Keefe, L. Seidman, B. Christensen, R. Hamer, T. Sharma, M. Sitskoorn, R. Lewine, D. Yurgelun-Todd, R. Gur, M. Tohen, G. Tollefson, T. Sanger, J. Lieberman (2004)
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.The American journal of psychiatry, 161 6
(1999)
The neuropathology of schizophrenia: a critical review of the data and their interpretation
(1990)
SAS/STAT User's Guide, Version 6
B. Ho, N. Andreasen, P. Nopoulos, Stephan Arndt, V. Magnotta, M. Flaum (2003)
Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.Archives of general psychiatry, 60 6
L. Selemon, J. Kleinman, M. Herman, P. Goldman-Rakic (2002)
Smaller frontal gray matter volume in postmortem schizophrenic brains.The American journal of psychiatry, 159 12
A. Denman (2004)
Schizophrenia (2nd edn)British Journal of Psychiatry, 184
D. Lewis (2002)
The Human Brain Revisited: Opportunities and Challenges in Postmortem Studies of Psychiatric DisordersNeuropsychopharmacology, 26
S. Kapur, R. Zipursky, P. Roy, Corey Jones, G. Remington, K. Reed, S. Houle (1997)
The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET studyPsychopharmacology, 131
P. Oosthuizen, R. Emsley, H. Turner, N. Keyter (2004)
A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis.The international journal of neuropsychopharmacology, 7 2
B. Andersen, B. Pakkenberg (2003)
Stereological quantitation in cerebella from people with schizophreniaBritish Journal of Psychiatry, 182
S. Kapur, P. Seeman (2001)
Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.The American journal of psychiatry, 158 3
J. Hedreen (1999)
Unbiased stereology?Trends in Neurosciences, 22
S. Nyberg, L. Farde, C. Halldin, Dahl Ml, L. Bertilsson (1995)
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate.The American journal of psychiatry, 152 2
R. Sweet, Sarah Bergen, Zhuoxin Sun, A. Sampson, D. Lewis (2004)
Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuitsBiological Psychiatry, 55
C. Andersson, R. Hamer, C. Lawler, R. Mailman, J. Lieberman (2002)
Striatal Volume Changes in the Rat Following Long-term Administration of Typical and Atypical Antipsychotic DrugsNeuropsychopharmacology, 27
J. Pierri, Christine Volk, S. Auh, A. Sampson, D. Lewis (2001)
Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia.Archives of general psychiatry, 58 5
M. Shenton, C. Dickey, Melissa Frumin, R. McCarley (2001)
A review of MRI findings in schizophreniaSchizophrenia Research, 49
A. Nordström, L. Farde, F. Wiesel, K. Forslund, S. Pauli, C. Halldin, G. Uppfeldt (1993)
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patientsBiological Psychiatry, 33
P. Hof, V. Haroutunian, V. Friedrich, W. Byne, Cristian Buitron, D. Perl, K. Davis (2003)
Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophreniaBiological Psychiatry, 53
M. Chakos, J. Lieberman, R. Bilder, M. Borenstein, G. Lerner, B. Bogerts, Houwei Wu, B. Kinon, M. Ashtari (1994)
Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.The American journal of psychiatry, 151 10
D. Cotter, D. Mackay, S. Landau, R. Kerwin, I. Everall (2001)
Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.Archives of general psychiatry, 58 6
P. Gadeberg, H. Gundersen, Finn Tågehøj (1999)
How accurate are measurements on MRI? a study on multiple sclerosis using reliable 3D stereological methodsJournal of Magnetic Resonance Imaging, 10
A. Stark, H. Uylings, E. Sanz-Arigita, B. Pakkenberg (2004)
Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia.The American journal of psychiatry, 161 5
S. Heckers, H. Heinsen, Birgit Geiger, Helmut Beckmann (1991)
Hippocampal neuron number in schizophrenia. A stereological study.Archives of general psychiatry, 48 11
F. Scheepers, C. Wied, H. Pol, W. Flier, J. Linden, R. Kahn (2001)
The Effect of Clozapine on Caudate Nucleus Volume in Schizophrenic Patients Previously Treated with Typical AntipsychoticsNeuropsychopharmacology, 24
P. Thompson, Christine Vidal, J. Giedd, P. Gochman, J. Blumenthal, R. Nicolson, A. Toga, J. Rapoport (2001)
Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophreniaProceedings of the National Academy of Sciences of the United States of America, 98
M. Niznikiewicz, M. Kubicki, M. Shenton (2003)
Recent structural and functional imaging findings in schizophreniaCurrent Opinion in Psychiatry, 16
L. Farde, A. Nordström, F. Wiesel, S. Pauli, C. Halldin, G. Sedvall (1992)
Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.Archives of general psychiatry, 49 7
R. Shader, D. Greenblatt (1986)
Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study.Journal of Clinical Psychopharmacology, 6
M. Kutner (1975)
Applied Linear Statistical Models
A. Sporn, D. Greenstein, N. Gogtay, N. Jeffries, M. Lenane, P. Gochman, L. Clasen, J. Blumenthal, J. Giedd, J. Rapoport (2003)
Progressive brain volume loss during adolescence in childhood-onset schizophrenia.The American journal of psychiatry, 160 12
S. Tauscher‐Wisniewski, J. Tauscher, J. Logan, B. Christensen, D. Mikulis, R. Zipursky (2002)
Caudate volume changes in first episode psychosis parallel the effects of normal aging: a 5-year follow-up studySchizophrenia Research, 58
(1979)
Stereological Methods. Volume 1: Practical Methods for Biological Morphometry
S. Kapur, R. Zipursky, Corey Jones, G. Remington, S. Houle, C. F.R.C.P. (2000)
Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.The American journal of psychiatry, 157 4
K. Young, L. Holcomb, Umar Yazdani, P. Hicks, D. German (2004)
Elevated neuron number in the limbic thalamus in major depression.The American journal of psychiatry, 161 7
T. Cullen, M. Walker, N. Parkinson, R. Craven, Paul Harrison (2003)
A postmortem study of the mediodorsal nucleus of the thalamus in schizophreniaSchizophrenia Research, 60
M. Keshavan, W. Bagwell, G. Haas, J. Sweeney, N. Schooler, J. Pettegrew (1994)
Changes in caudate volume with neuroleptic treatmentThe Lancet, 344
Exposure to antipsychotics and brain size K-A Dorph-Petersen et al
P. Murali, Doraiswamy, L. Tupler, K. Krishnan (1995)
Neuroleptic treatment and caudate plasticityThe Lancet, 345
S. Kapur, R. Zipursky, G. Remington, Corey Jones, J. DaSilva, Alan Wilson, S. Houle (1998)
5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.The American journal of psychiatry, 155 7
G. Rajkowska, A. Halaris, L. Selemon (2001)
Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorderBiological Psychiatry, 49
L. Selemon, M. Lidow, P. Goldman-Rakic (1999)
Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposureBiological Psychiatry, 46
H. Gundersen, E. Jensen (1987)
The efficiency of systematic sampling in stereology and its prediction *Journal of Microscopy, 147
S. Gupta, R. Kunka, A. Metz, T. Lloyd, G. Rudolph, J. Perel (1995)
Effect of Alosetron (a New 5‐HT3 Receptor Antagonist) on the Pharmacokinetics of Haloperidol in Schizophrenic PatientsThe Journal of Clinical Pharmacology, 35
B. Pakkenberg (1987)
Post-mortem Study of Chronic Schizophrenic BrainsBritish Journal of Psychiatry, 151
A. Løkkegaard, J. Nyengaard, M. West (2001)
Stereological estimates of number and length of capillaries in subdivisions of the human hippocampal regionHippocampus, 11
K. Dorph‐Petersen, J. Pierri, Zhuoxin Sun, A. Sampson, D. Lewis (2004)
Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell typesJournal of Comparative Neurology, 472
D. Cotter, D. Mackay, G. Chana, C. Beasley, S. Landau, I. Everall (2002)
Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.Cerebral cortex, 12 4
A. Büttner, P. Mehraein, S. Weis (1996)
Vascular changes in the cerebral cortex in HIV-1 infectionActa Neuropathologica, 92
C. Read, Y. Hochberg, Ajit Tamhane (1989)
Multiple Comparison Procedures.Biometrics, 45
PJ Harrison, DA Lewis (2003)
Schizophrenia
S. Mendis‐Handagama, L. Ewing (1990)
Sources of error in the estimation of Leydig cell numbers in control and atrophied mammalian testesJournal of Microscopy, 159
It is unclear to what degree antipsychotic therapy confounds longitudinal imaging studies and post-mortem studies of subjects with schizophrenia. To investigate this problem, we developed a non-human primate model of chronic antipsychotic exposure. Three groups of six macaque monkeys each were exposed to oral haloperidol, olanzapine or sham for a 17–27 month period. The resulting plasma drug levels were comparable to those seen in subjects with schizophrenia treated with these medications. After the exposure, we observed an 8–11% reduction in mean fresh brain weights as well as left cerebrum fresh weights and volumes in both drug-treated groups compared to sham animals. The differences were observed across all major brain regions (frontal, parietal, temporal, occipital, and cerebellum), but appeared most robust in the frontal and parietal regions. Stereological analysis of the parietal region using Cavalieri's principle revealed similar volume reductions in both gray and white matter. In addition, we assessed the subsequent tissue shrinkage due to standard histological processing and found no evidence of differential shrinkage due to drug exposure. However, we observed a pronounced general shrinkage effect of ∼20% and a highly significant variation in shrinkage across brain regions. In conclusion, chronic exposure of non-human primates to antipsychotics was associated with reduced brain volume. Antipsychotic medication may confound post-mortem studies and longitudinal imaging studies of subjects with schizophrenia that depend upon volumetric measures.
Neuropsychopharmacology – Springer Journals
Published: Mar 9, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.